Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 34380C201 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Bleichroeder LP
13G/A
Amendment 1
|
8.2% |
8/13/2026
Event 6/30/2026
|
|
| Bleichroeder LP | 8.2% | ||
| Bleichroeder Holdings LLC | 8.2% | ||
| Andrew Gundlach | 8.2% | ||
|
Frost Phillip MD Et Al
13D/A
Amendment 27
|
24.7% |
1/28/2026
Event 12/22/2025
|
|
| Phillip Frost, M.D. | 24.7% | ||
| Frost Gamma Investments Trust | 24.7% | ||
|
Bleichroeder LP
13G
|
9.6% |
11/14/2025
Event 9/30/2025
|
|
| Bleichroeder LP | 9.6% | ||
| Bleichroeder Holdings LLC | 9.6% | ||
| Andrew Gundlach | 9.6% | ||
| Tieton Capital Management, LLC 13G/A Amendment 2 | 4.5% |
11/12/2025
Event 9/30/2025
|
|
|
Frost Phillip MD Et Al
13D/A
Amendment 26
|
28.3% |
8/26/2025
Event 8/19/2025
|
|
| Phillip Frost, M.D. | 28.3% | ||
| Frost Gamma Investments Trust | 28.3% | ||
| Conlin Matthew 13D/A Amendment 6 | 16.1% |
6/20/2025
Event 6/18/2025
|
|
| Schulke Ryan 13D/A Amendment 7 | 21.1% |
6/20/2025
Event 6/18/2025
|
|
|
Frost Phillip MD Et Al
13D/A
Amendment 25
|
31.1% |
5/23/2025
Event 5/19/2025
|
|
| Phillip Frost, M.D. | 31.1% | ||
| Frost Gamma Investments Trust | 31.1% | ||
|
Frost Phillip MD Et Al
13D/A
Amendment 24
|
23.7% |
4/2/2025
Event 3/20/2025
|
|
| Phillip Frost, M.D. | 23.7% | ||
| Frost Gamma Investments Trust | 23.7% | ||
|
Global Value Investment Corp.
13D/A
Amendment 4
|
15.0% |
1/22/2025
Event 1/17/2025
|
|
| Global Value Investment Corporation | 15.0% | ||
| Jeffrey R. Geygan | 15.0% | ||
| James P. Geygan | 15.0% | ||
| Stacy A. Wilke | 15.0% | ||
| Kathleen M. Geygan | 15.0% | ||
| Shawn G. Rice | 15.0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 28 | 4.38 M | $16.3 M |
| 2026 Q1 | 30 | 4.63 M | $14.6 M |
| 2025 Q4 | 26 | 4.35 M | $10.4 M |
| 2025 Q3 | 28 | 6.72 M | $14.9 M |
| 2025 Q2 | 26 | 4.95 M | $9.90 M |
| 2025 Q1 | 28 | 4.97 M | $10.8 M |
| 2024 Q4 | 30 | 5.24 M | $13.2 M |
| 2024 Q3 | 23 | 1.64 M | $6.02 M |
| 2024 Q2 | 26 | 1.63 M | $5.88 M |
| 2024 Q1 | 1 | 12.3 k | $6.06 k |